搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
Pharmaceutical Technology
17 小时
CPHI Europe: Targeting supply chain bottlenecks key for cell and gene therapies
At CPHI Europe, Angela Vollstedt, global director of Cell & Gene Therapies at Novartis discussed scale up strategies for cell ...
Pharmaceutical Technology
19 小时
South Korean company Dong-A ST wins FDA approval for Stelara biosimilar
Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for the treatment of certain autoimmune diseases.
Pharmaceutical Technology
21 小时
FDA AdCom votes in favour of Stealth’s Barth syndrome drug
The Cardiovascular and Renal Drugs Advisory Committee voted 10-6 in support of Stealth’s elamipretide for the ultra-rare ...
Pharmaceutical Technology
22 小时
Roche wins first-line approval for PI3K inhibitor combo in breast cancer
The US FDA approved Itovebi in combination with Pfizer’s Ibrance and AstraZeneca’s Faslodex for certain breast cancer ...
Pharmaceutical Technology
23 小时
Global awareness and geographic variations of plaque psoriasis
Plaque psoriasis is a chronic condition that affects millions yet is often misunderstood or underappreciated in terms of its ...
Pharmaceutical Technology
1 天
XtalPi’s AI biologics discovery platform licensed to Janssen Biotech
XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen Biotech for advanced biotherapeutics ...
Pharmaceutical Technology
1 天
Booster Therapeutics to develop proteasome activator medicines
Booster Therapeutics has announced its inception to develop a new class of proteasome activator medicines for ...
Pharmaceutical Technology
1 天
KeyBioscience and Eli Lilly extend partnership for obesity treatments
KeyBioscience and Eli Lilly have extended their partnership to develop a new class of treatments for obesity and associated ...
Pharmaceutical Technology
1 天
CPHI Europe: Overcoming the unique challenges with high-concentration mAbs
High-concentration monoclonal antibodies (mAbs) are gaining prominence given the compliance and cost advantages.
Pharmaceutical Technology
1 天
Merck unveils $318m biosafety testing facility in Maryland, US
Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m) biosafety testing facility in Rockville, Maryland, ...
Pharmaceutical Technology
1 天
Activist investor Starboard cries foul play in exec U-turn at Pfizer
Pfizer’s former CEO Ian Read and former CFO Frank D’Amelio now back the pharma, despite originally siding with Starboard.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈